196 related articles for article (PubMed ID: 32897268)
1. Phenotype of definite familial hypercholesterolemia with negative genetic study in Argentina.
Corral P; Bañares V; Sáenz B; Zago V; Sarobe A; López G; Berg G; Schreier L
Arch Cardiol Mex; 2020; 90(2):130-136. PubMed ID: 32897268
[TBL] [Abstract][Full Text] [Related]
2. Fenotipo de hipercolesterolemia familiar definitivo con estudio genético negativo en Argentina.
Corral P; Bañares V; Sáenz B; Zago V; Sarobe A; López G; Berg G; Schreier L
Arch Cardiol Mex; 2020; 90(2):151-157. PubMed ID: 32459195
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetics of familial hypercholesterolemia in Israel-revisited.
Durst R; Ibe UK; Shpitzen S; Schurr D; Eliav O; Futema M; Whittall R; Szalat A; Meiner V; Knobler H; Gavish D; Henkin Y; Ellis A; Rubinstein A; Harats D; Bitzur R; Hershkovitz B; Humphries SE; Leitersdorf E
Atherosclerosis; 2017 Feb; 257():55-63. PubMed ID: 28104544
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of familial hypercholesterolemia in Asian Indians: A single-center study.
Setia N; Movva S; Balakrishnan P; Biji IK; Sawhney JPS; Puri R; Arora A; Puri RD; Saxena R; Mishra S; Apte S; Kulshrestha S; Ramprasad VL; Verma IC
J Clin Lipidol; 2020; 14(1):35-45. PubMed ID: 32044282
[TBL] [Abstract][Full Text] [Related]
5. Mutation spectrum and polygenic score in German patients with familial hypercholesterolemia.
Rieck L; Bardey F; Grenkowitz T; Bertram L; Helmuth J; Mischung C; Spranger J; Steinhagen-Thiessen E; Bobbert T; Kassner U; Demuth I
Clin Genet; 2020 Nov; 98(5):457-467. PubMed ID: 32770674
[TBL] [Abstract][Full Text] [Related]
6. Lipid phenotype and heritage pattern in families with genetic hypercholesterolemia not related to LDLR, APOB, PCSK9, or APOE.
Jarauta E; Pérez-Ruiz MR; Pérez-Calahorra S; Mateo-Gallego R; Cenarro A; Cofán M; Ros E; Civeira F; Tejedor MT
J Clin Lipidol; 2016; 10(6):1397-1405.e2. PubMed ID: 27919357
[TBL] [Abstract][Full Text] [Related]
7. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I
Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study.
Pirillo A; Garlaschelli K; Arca M; Averna M; Bertolini S; Calandra S; Tarugi P; Catapano AL;
Atheroscler Suppl; 2017 Oct; 29():17-24. PubMed ID: 28965616
[TBL] [Abstract][Full Text] [Related]
9. The island of Gran Canaria: A genetic isolate for familial hypercholesterolemia.
Sánchez-Hernández RM; Tugores A; Nóvoa FJ; Brito-Casillas Y; Expósito-Montesdeoca AB; Garay P; Bea AM; Riaño M; Pocovi M; Civeira F; Wägner AM; Boronat M
J Clin Lipidol; 2019; 13(4):618-626. PubMed ID: 31153816
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan.
Hsiung YC; Lin PC; Chen CS; Tung YC; Yang WS; Chen PL; Su TC
Atherosclerosis; 2018 Oct; 277():440-447. PubMed ID: 30270083
[TBL] [Abstract][Full Text] [Related]
11. The familial hypercholesterolaemia phenotype: Monogenic familial hypercholesterolaemia, polygenic hypercholesterolaemia and other causes.
Mariano C; Alves AC; Medeiros AM; Chora JR; Antunes M; Futema M; Humphries SE; Bourbon M
Clin Genet; 2020 Mar; 97(3):457-466. PubMed ID: 31893465
[TBL] [Abstract][Full Text] [Related]
12. Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland.
Björnsson E; Thorgeirsson G; Helgadóttir A; Thorleifsson G; Sveinbjörnsson G; Kristmundsdóttir S; Jónsson H; Jónasdóttir A; Jónasdóttir Á; Sigurðsson Á; Guðnason T; Ólafsson Í; Sigurðsson EL; Sigurðardóttir Ó; Viðarsson B; Baldvinsson M; Bjarnason R; Danielsen R; Matthíasson SE; Thórarinsson BL; Grétarsdóttir S; Steinthórsdóttir V; Halldórsson BV; Andersen K; Arnar DO; Jónsdóttir I; Guðbjartsson DF; Hólm H; Thorsteinsdóttir U; Sulem P; Stefánsson K
Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2616-2628. PubMed ID: 34407635
[TBL] [Abstract][Full Text] [Related]
13. Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.
Amor-Salamanca A; Castillo S; Gonzalez-Vioque E; Dominguez F; Quintana L; Lluís-Ganella C; Escudier JM; Ortega J; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
J Am Coll Cardiol; 2017 Oct; 70(14):1732-1740. PubMed ID: 28958330
[TBL] [Abstract][Full Text] [Related]
14. Cascade Screening for Familial Hypercholesterolemia in South Africa: The Wits FIND-FH Program.
Raal FJ; Bahassi EM; Stevens B; Turner TA; Stein EA
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2747-2755. PubMed ID: 32878475
[TBL] [Abstract][Full Text] [Related]
15. Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.
Al-Allaf FA; Athar M; Abduljaleel Z; Taher MM; Khan W; Ba-Hammam FA; Abalkhail H; Alashwal A
Gene; 2015 Jul; 565(1):76-84. PubMed ID: 25839937
[TBL] [Abstract][Full Text] [Related]
16. The
Meshkov A; Ershova A; Kiseleva A; Zotova E; Sotnikova E; Petukhova A; Zharikova A; Malyshev P; Rozhkova T; Blokhina A; Limonova A; Ramensky V; Divashuk M; Khasanova Z; Bukaeva A; Kurilova O; Skirko O; Pokrovskaya M; Mikova V; Snigir E; Akinshina A; Mitrofanov S; Kashtanova D; Makarov V; Kukharchuk V; Boytsov S; Yudin S; Drapkina O
Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33418990
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of mutations in index patients with familial hypercholesterolemia in Singapore: Single center study.
Pek SLT; Dissanayake S; Fong JCW; Lin MX; Chan EZL; Tang JI; Lee CW; Ong HY; Sum CF; Lim SC; Tavintharan S
Atherosclerosis; 2018 Feb; 269():106-116. PubMed ID: 29353225
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the genetic background of individuals with a clinical familial hypercholesterolemia phenotype.
Medeiros AM; Alves AC; Miranda B; Chora JR; Bourbon M;
J Lipid Res; 2024 Feb; 65(2):100490. PubMed ID: 38122934
[TBL] [Abstract][Full Text] [Related]
19. Founder effects facilitate the use of a genotyping-based approach to molecular diagnosis in Swedish patients with familial hypercholesterolaemia.
Benedek P; Jiao H; Duvefelt K; Skoog T; Linde M; Kiviluoma P; Kere J; Eriksson M; Angelin B
J Intern Med; 2021 Aug; 290(2):404-415. PubMed ID: 33955087
[TBL] [Abstract][Full Text] [Related]
20. Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia.
Ohta N; Hori M; Takahashi A; Ogura M; Makino H; Tamanaha T; Fujiyama H; Miyamoto Y; Harada-Shiba M
J Clin Lipidol; 2016; 10(3):547-555.e5. PubMed ID: 27206942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]